Literature DB >> 1694041

T cell reactivity to MHC molecules: immunity versus tolerance.

J Sprent1, E K Gao, S R Webb.   

Abstract

The specificity of mature CD8+ and CD4+ T lymphocytes is controlled by major histocompatibility complex (MHC) class I and class II molecules, respectively. The MHC class specificity of T cells is stringent in many assays, but is less evident when cells are supplemented with exogenous lymphokines. The repertoire of T cells is shaped through contact with MHC molecules in the thymus and involves a complex process of positive selection and negative selection (tolerance). Tolerance of immature T cells to MHC molecules can reflect either clonal deletion or anergy and results from intrathymic contact with several cell types, including epithelial cells and cells with antigen-presenting function. Unlike immature T cells, mature T cells are relatively resistant to tolerance induction. In certain situations partial unresponsiveness of mature T cells can be achieved by exposing T cells to foreign MHC molecules expressed on atypical antigen-presenting cells. Tolerance is rarely complete, however, and the precise requirements for tolerizing mature T cells are still unclear.

Mesh:

Substances:

Year:  1990        PMID: 1694041     DOI: 10.1126/science.1694041

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

1.  Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses.

Authors:  Z Grossman; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  T cell receptor V beta variable gene family expression in human peripheral blood lymphocytes at the mRNA and membrane protein level.

Authors:  H Z Hu; R A de Weger; K Bosboom-Kalsbeek; M G Tilanus; J Rozing; H J Schuurman
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Thymocyte development is normal in CTLA-4-deficient mice.

Authors:  C A Chambers; D Cado; T Truong; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.

Authors:  C Schmidt; S R Burrows; T B Sculley; D J Moss; I S Misko
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

5.  A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.

Authors:  D E Smilek; D C Wraith; S Hodgkinson; S Dwivedy; L Steinman; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

6.  Antiviral immune responses in Itk-deficient mice.

Authors:  M F Bachmann; D R Littman; X C Liao
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 7.  The golden anniversary of the thymus.

Authors:  Jacques F A P Miller
Journal:  Nat Rev Immunol       Date:  2011-05-27       Impact factor: 53.106

8.  Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation.

Authors:  Yang Zeng; Tongtong Gao; Guangyu Zhao; Yuting Jiang; Yi Yang; Hong Yu; Zhihua Kou; Yuchun Lone; Shihui Sun; Yusen Zhou
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

9.  Tolerance of CD8+ T cells developing in parent-->F1 chimeras prepared with supralethal irradiation: step-wise induction of tolerance in the intrathymic and extrathymic environments.

Authors:  H Kosaka; J Sprent
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

10.  Resting and activated T cells display different requirements for CD8 molecules.

Authors:  Z Cai; J Sprent
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.